 Home > Active Ingredient News > Drugs Articles > The most fuel-burning medicine! Collection, catalog adjustment, online sales of prescription drugs, Chinese medicine... Did the 22 big men speak your mind?

The most fuel-burning medicine! Collection, catalog adjustment, online sales of prescription drugs, Chinese medicine... Did the 22 big men speak your mind?

 Last Update: 2021-03-21
 Source: Internet
 Author: User

Tags

ethylene point group

3 4 methylenedioxymethamphetamine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

311，，。，，，，，，，，，、，。22，、、、、、、、、、……？

：“”，“”

、

，：，，；，，。、、、、。

，，，，。，，。

：

、

，：、。：，，，，，，；，，、、、，、、、、、、，，、；，，。

，。，6.

68/10，，，。

，。，6.
68/10，，，。

：

、、

202012，、、、、，，、，。

，，，。，/，，，、，，，。

：

、

，、，，，、、。

，，。，《》(GTP)；，，；，、、，，/；，，，，，。，，，。

：

、

For my country's high-performance medical device industry, to transform mature laboratory technology into clinically applied medical products, it needs to go through a long period of clinical and registration, as well as issues such as market stability and business expansion.

Yuan Yuyu suggested that the huge demand of the domestic market should be used to promote technological upgrading and industrial development, and the scientific research orientation of basic laboratory research should be transformed into market demand orientation, so as to promote the further transformation of innovation achievements and narrow the gap with international advanced technology.

In terms of suggestions for increasing market-oriented transformation, Yuan Yuyu believes that one is to vigorously cultivate innovative small and medium-sized enterprises; the other is to give full play to market advantages and "string up" the chain of industry and market; and the third is to increase talent support.

Medicine point two medicine point two

Drug circulation

Drug distribution drug distribution

Ding Lieming: Innovative supervision "escorts" online prescription drugs

Ding Lieming, deputy to the National People's Congress and chairman of Betta Pharmaceutical Co.
, Ltd.

Ding Lieming is concerned that the flexibility and convenience of online drug sales have played an important role in ensuring the basic drug needs of the public.
However, there are also many problems in online prescription drugs that require attention.
To this end, he suggested innovative regulatory measures to prevent the abuse of prescription drugs sold online.

Ding Lie stated that it is necessary to first revise and improve relevant laws and regulations such as the online drug transaction management measures; secondly, use the medical consortium as a unit to open up online and offline prescription information systems to achieve national prescription information sharing; third, according to drug risks and needs, The online sales of prescription drugs shall be regulated in an orderly manner.
“First, let go of the online sales of prescription drugs for chronic diseases, and then gradually release some prescription drugs for common diseases, continue to standardize the process of online prescription drugs, and form strict online prescription drug standards.
” Finally, should Improve the medical insurance payment mechanism for online purchase of prescription drugs as soon as possible, and support the innovative development of the "Internet + medicine" service model.

Xiao Wei: Scientifically carry out centralized procurement of Chinese patent medicines

Xiao Wei, deputy to the National People's Congress, Chairman and Secretary of the Party Committee of Jiangsu Kangyuan Group Co.
, Ltd.

Proprietary Chinese medicines will soon be included in the scope of centralized mass procurement.
This is a major event to enhance people’s well-being and promote the healthy development of the pharmaceutical industry.
Xiao Wei expects relevant departments to combine the development of traditional Chinese medicine to establish centralized mass procurement that meets the complex characteristics and unique attributes of traditional Chinese medicine.
The management model promotes and supports the inheritance and innovative development of traditional Chinese medicine, strictly and rationally uses medicines, and ensures that clinical medicines are safer and more effective.

Xiao Wei suggested that according to the complexity of Chinese patent medicines, the generic name of the competition unit should be given full consideration to implement high-quality and high-priced Chinese patent medicines on the basis of quality stratification; based on the innovation of Chinese medicine, it is recommended to develop a special concentration zone for innovative Chinese medicines.
According to the specific needs of the clinical application of Chinese patent medicines, it is recommended to formulate special protection policies to ensure the needs of clinical use; according to the basic attributes of the production cost of Chinese patent medicines, it is recommended to develop a scientific drug cost price evaluation system.

In addition, in terms of improving the evaluation system of technological innovation in traditional Chinese medicine, Xiao Wei suggested that one is to explore the establishment of an independent and autonomous evaluation system led by traditional Chinese medicine; the other is to systematically study the characteristics of traditional Chinese medicine, and closely combine the characteristics of the evaluation objects to establish classification evaluations.
Mechanism; the third is to develop an objective, standardized, and specialized third-party TCM technology evaluation institution; the fourth is to carry out methodological research on TCM technology evaluation, and gradually establish an evaluation standard and methodological system suitable for the characteristics of TCM.

Zhang Feng: Deepening the procurement reform of national market-oriented pharmaceutical groups

Zhang Feng, member of the National Committee of the Chinese People's Political Consultative Conference and Vice Chairman of Shenzhen Neptunus Group Co.
, Ltd.

Shenzhen has taken the lead in implementing a pilot market-led drug procurement reform, relying on a professional third-party platform to establish an "Internet + drug supply" system.
Zhang Feng mentioned that Shenzhen's experience should be thoroughly summarized to form a model that can be replicated and promoted.
He believes that we should start by improving relevant regulations and policies to guide the standardized development of third-party organizations.

Zhang Feng specifically suggested that the relevant competent authorities can refer to the national "4+7" drug centralized procurement practice, and provide adequate policy support for drug group procurement in the entire process of opening up bidding, procurement, use, payment, and payment, and further explore And improve the medical insurance payment reform, medical insurance fund prepayment, online settlement, and guaranteed quantity purchasing mode.

Medicine point three

Medicine point three
medicine point three

Perfect system

System perfection system perfection

Zhao Chao: Strengthening the protection of intellectual property rights for small and medium-sized technological enterprises

Zhao Chao, representative of the National People's Congress and President of Shandong Buchang Pharmaceutical Co.

, Ltd.

Technology-based small and medium-sized enterprises are an important part of my country's small and medium-sized enterprises.

Intellectual property has also become another important production factor after land, capital and labor.

Technology-based small and medium-sized enterprises are an important part of my country's small and medium-sized enterprises.

Zhao Chao suggested that one is to increase support for intellectual property rights protection, and at the same time increase penalties for intellectual property infringements and violations; the second is to increase the public’s awareness of intellectual property protection, help companies increase their awareness of intellectual property rights, and coach technology-based companies Carry out intellectual property planning and layout; third, relevant governments at all levels have introduced some powerful protection measures to provide appropriate incentives to enterprises or social groups that actively protect their intellectual property rights; fourth, promote the active service awareness of relevant governments and professional organizations at all levels Establish assistance centers for intellectual property rights protection at all levels; fifth, streamline related administrative and judicial trial procedures in intellectual property cases; sixth, improve legislation for new forms of infringement such as network intellectual property rights infringement.

In addition, in the context of the aging population and the increasing incidence of chronic diseases, Zhao Chao suggested that the role of Chinese medicine in the prevention and treatment of chronic diseases is promoted to promote the high-quality development of Chinese medicine.

Chen Baohua: Speed up the establishment and improvement of my country's drug patent linkage system

Chen Baohua, representative of the National People's Congress and President of Zhejiang Huahai Pharmaceutical Co.
, Ltd.

Facing the medical pressure caused by the increasingly serious ageing, many developed countries have established patent linkage systems and introduced relevant policies to promote the substitution of generic drugs, promote the development of the pharmaceutical industry, and have achieved remarkable results.
my country is a big country of generic drugs, but it is large but not strong.
One of the main reasons is that the construction of my country's drug patent linkage system is seriously lagging, which restricts the motivation of generic drug companies to challenge patents to preempt imitation, and thus restricts the development and imitation of my country's generic drug industry.
Pharmaceutical alternatives.
Therefore, it is necessary to deepen the reform of related systems and speed up the establishment and improvement of my country's drug "patent linkage" system.

Chen Baohua suggested speeding up the revision and improvement of the "China Listed Drug Catalogue", perfecting the "patent period compensation" system, perfecting the "market exclusivity period" system for the first generic drugs, establishing a "simplified new drug application" system, and clearly stipulating the "first imitation date" and "patent period compensation" system.
In the scope of “first copyists”, establish a patent link-related mechanism to ensure the implementation of the patent link system, and play the role of “pull” the use link and “guarantee” the supervision link.

Yu Qingming: Speeding up the reform of the price system of medical service items

Yu Qingming, representative of the National People's Congress, Chairman and Secretary of the Party Committee of Sinopharm Holdings Co.
, Ltd.

Yu Qingming said that, on the whole, my country's pharmaceutical and device industries have entered a development cycle of increasing concentration and innovation and upgrading, and further linkage and supporting of reforms in key areas and key links of the three medical linkages are needed.

In terms of medical innovation, he suggested to continue to accelerate the reform of the price system of medical service items, appropriately simplify the approval process, and establish a complete policy support system from product registration to clinical approval services, including the entire industry chain and supply chain covering the entire medical terminal.
Encourage innovation in medicines and devices.

Regarding the reform of the drug distribution system, what urgently needs to be solved is the coordination of the medical distribution management policies of various regions, opening up the channels of medical third-party logistics and multi-site operations in different places, improving the consistency of policy understanding and implementation in various regions, and encouraging the use of modern information.
The traceability technology for supply chain management.

Fang Tonghua: Do a good job in the dynamic adjustment and management of the national essential medicine catalog

Fang Tonghua, deputy to the National People's Congress and Chairman of Treasure Island

As the basic basis for medical institutions to equip and use drugs, the National Essential Drug List has a strong policy orientation in guiding and guaranteeing medical services and medical insurance reimbursement.

Fang Tonghua suggested that the restrictions on the dosage forms and specifications of the basic drug catalog should be liberalized to prevent a small number of pharmaceutical companies from using exclusive dosage forms and specifications to obtain the "privilege" of entering the basic drug catalog, causing unfair competition in the drug catalog; secondly, consolidate the results of the prevention and control of the new crown epidemic.
The drugs included in the provincial list of traditional Chinese medicine prevention and treatment programs for new coronary pneumonia will be given priority to be included in the national basic medicine list; third, pay attention to the results of the adjustment of the provincial basic medicine list.
By the end of 2019, it has entered more than 3 (inclusive) provincial supplements The medicines in the basic medicine catalog can be included in the national basic medicine catalog; fourth, to provide key support for the varieties of traditional Chinese medicines, and to add more proprietary Chinese medicines to the national basic medicine catalog, so that the proportion of Chinese and Western medicines is relatively balanced; fifth, encourage local participation in catalog adjustments , The provinces will first carry out the selection of drugs, and then report to the country for review and selection.

Wang Weidong: Bio-innovative drugs that have been approved for marketing should enter medical insurance as soon as possible

Wang Weidong, deputy to the National People's Congress and chairman of Yantai Rongchang Pharmaceutical Co.
, Ltd.

Wang Weidong said that the reform of the drug approval system has greatly improved the speed and efficiency of review, but there is still room for further improvement in the implementation process; it is necessary to attach great importance to and pay attention to the transformation and industrialization of biomedical technology innovations to achieve industrialization.
, Support high-quality development.

At present, bio-innovative drugs are mainly entered into medical insurance through negotiation.
He suggested that bio-innovative drugs that have been approved for marketing should enter the medical insurance system as soon as possible to increase product accessibility; secondly, comprehensive consideration should be given to the characteristics of biologics, R&D costs and cycle, Factors such as production cost, production line construction, etc.
, fully consider the actual affordability of the company during price negotiations, and can achieve a reasonable balance between price and purchase volume or other aspects, so as to fully mobilize the enthusiasm of the company for innovation.

Ankang: Speeding up the construction of local batch issuing inspection institutions

Ankang, deputy to the National People's Congress and chairman of Hualan Bioengineering Co.
, Ltd.

Ankang said that the current increasing production of biological products has put a lot of pressure on batch issuing agencies.
For example, it takes 2 to 3 months for batch issuing inspection time for vaccine products from delivery to market.
And production enterprises have caused certain supply pressure and economic pressure.
Ankang suggested that all provinces speed up the construction of batch-issuing inspection agencies to reduce the burden of the current "1+9" inspection agencies, shorten the batch-issuing inspection time, reduce the cost of enterprise inspection products and product storage, and speed up the time for biological products to enter the market.

In terms of drug safety, Ankang recommends that relevant departments take countermeasures as soon as possible, increase the number of drug review staff, strengthen the power of drug review and approval departments, and perform drug regulatory functions more effectively, while taking on the important task of promoting the development of China's pharmaceutical industry, so that my country The pharmaceutical economy has achieved faster and healthier development.

Medicine point four

Medicine point four
medicine point four

Development of Chinese Medicine

Development of Chinese Medicine Development of Chinese Medicine

Geng Funeng: Develop the cultivation of Chinese medicinal materials to help rural revitalization

Geng Funeng, deputy to the National People's Congress and chairman of Good Doctor Group

Regarding the development of the modern industrial system of traditional Chinese medicine, Geng Funeng suggested that one is to vigorously develop the construction of Chinese medicinal material bases, establish a medicinal material traceability system, and pass the protection of national geographical indications; second, establish a new drug research and development system based on the theory of Chinese medicine and guided by clinical value ; The third is to vigorously develop traditional Chinese medicine education; the fourth is to increase the amount and proportion of medical insurance reimbursement for traditional Chinese medicine products; the fifth is to increase the protection of intellectual property rights in traditional Chinese medicine.

Geng Funeng believes that traditional Chinese medicine has great advantages in the development of characteristic industries in rural areas and is of great significance to the realization of rural revitalization.

He suggested that one is to "anchor" characteristic industries in areas where poverty is alleviated, to vigorously develop the cultivation of Chinese medicinal materials, to establish a complete industrial chain, to promote the transformation of "medicinal materials" into "pharmaceuticals", and to improve economic efficiency; the second is to strengthen technical guidance to growers , To boost the quality and efficiency of the Chinese medicinal material planting economy; the third is to increase the cultivation of Chinese medicinal materials brand and build a characteristic Chinese medicinal material production and processing base; the fourth is to actively build model demonstration villages to play a leading role in realizing agricultural and rural modernization.

Chinese herbal powder decoction pieces are an indispensable part of traditional Chinese medicine decoction pieces, which have important clinical significance, as well as huge social and economic value.
Geng Funeng suggested that one is to establish an evaluation system based on the theory of Chinese medicine and oriented by clinical value; the other is to determine the formulation of standards for powdered Chinese medicine according to the principles of "safe, effective, and controllable quality".

Wu Xiangjun: Promote the sustainable use of wild Chinese medicine resources

、

，，，、。，，，。

，，，；，；。

：

、、

，，，，，，“”。

，，、、，，。

：“”

、

，，，。，，，，，，。

，：，，，。

，，“”。，，；，；“”，。

Wu Xinbin: Cracking down on false advertising of Chinese medicine

Wu Xinbin, deputy to the National People's Congress and chief engineer of Tus-Guhan Group Co.
, Ltd.

Traditional Chinese medicine is a treasure of the Chinese nation, and it has made great contributions to disease prevention, disease treatment, and rehabilitation of the common people.
But at present, some businesses are pursuing profit, using media platforms to promote the role of Chinese medicine out of context, and even package them as a "magic medicine" that can cure all diseases, harming the interests of the people.

She suggested that the relevant departments should organize experts in the industry to review and clarify the propaganda involving Chinese medicine, notify the stop of propaganda that does not comply with laws and regulations, false curative effects, and exaggeration.
If necessary, clarify and apologize for previous false propaganda.
Explain and eliminate the impact.
It is also necessary to strengthen supervision and management of the advertisements of local TV stations.
The advertisements must be reviewed in various industries.
It is strictly forbidden to exaggerate false propaganda.
You cannot give up social responsibility for economic benefits.
You can set up a public reporting hotline for problems that cannot be supervised.
, Closed together, so that Chinese medicine can develop healthily in a good environment.

Medicine point five

Medicine point five
medicine point five

Consolidate the results of the fight against the epidemic

Consolidate the achievements in the fight against the epidemic

Zhang Boli: Including the medical expenses of patients with new coronary pneumonia during the recovery period into medical insurance

Zhang Boli, representative of the National People's Congress, President of Tianjin University of Traditional Chinese Medicine, Academician of the Chinese Academy of Engineering

According to reports, the probability and severity of the sequelae of the new crown in the United States and Europe are more serious than in my country, and the issue of sequelae has attracted attention at home and abroad.
Zhang Boli said that my country also urgently needs to carry out timely and comprehensive rehabilitation interventions in traditional Chinese and Western medicine.
At the same time, it actively sums up the rehabilitation programs and experiences of traditional Chinese and Western medicine, standardizes them, and conducts long-term follow-up visits.

Zhang Boli suggested that first, relevant departments should pay great attention to the rehabilitation of patients with new coronary pneumonia, carry out scientific research on the rehabilitation of new coronary pneumonia, and establish unified Chinese and Western medicine rehabilitation treatment plans and evaluation standards; second, establish designated rehabilitation hospitals and carry out rehabilitation training for medical staff , And establish a rehabilitation platform for long-term follow-up observation and evaluation; third is to introduce relevant policies and measures to encourage patients to take the initiative to recover, recover at home, and consciously participate in rehabilitation; fourth, adhere to the principle of equal emphasis on traditional Chinese and Western medicine, and use both Chinese and Western medicine in the rehabilitation work; fifth, recommendations Relevant departments will include the medical expenditures of patients with new coronary pneumonia during the recovery period into medical insurance, and provide appropriate proportions for reimbursement.
The relevant departments provide support in the research and development and registration of rehabilitation drugs and devices.

Chen Wei: Building a National Technology Innovation Center for Specially Needed Vaccines

Chen Wei, member of the National Committee of the Chinese People's Political Consultative Conference, director of the Institute of Bioengineering of the Academy of Military Medicine of the Academy of Military Sciences, and academician of the Chinese Academy of Engineering

Chen Wei suggested building a national technological innovation center for special-needed vaccines to help national biosecurity and social stability.
She said that only by mastering key core technologies in her own hands can we fundamentally guarantee economic and social development, the country's long-term stability, and people's lives and health.

Chen Wei pointed out that my country still has some shortcomings in biotechnology innovation, including insufficient top-level design and scientific coordination, scattered research forces, unsound long-term support mechanisms, unstable basic research, imperfect conditions and facilities, and inadequate rapid response systems.
Sound and so on.
Therefore, it is recommended that the first is to establish a “white list” system for major national safety and technological research; the second is to build a national technological innovation center for special-needed vaccines; the third is to continue to carry out scientific research on the prevention and control of the new crown epidemic; the fourth is to create a good scientific research ecology with concentrated basic research.

Dai Lizhong: Give full play to the effectiveness of established nucleic acid detection capabilities

Dai Lizhong, deputy to the National People's Congress and chairman of Shengxiang Biotechnology Co.
, Ltd.

According to the latest data from the State Council’s Joint Prevention and Control Mechanism, as of January 13, 2021, there are 8,437 medical and health institutions nationwide that can carry out nucleic acid testing, which is four times the number of medical and health institutions that can carry out nucleic acid testing at the end of March 2020, and has comprehensive coverage.
County-level medical and health institutions.

Dai Lizhong suggested that there are currently more than 8,400 medical and health institutions with nucleic acid detection capabilities, and they should make the best use of their materials to quickly transform them into the backbone of the disease prevention and control system, and build a prevention-oriented disease prevention and control system; increase prevention.
The proportion of medical insurance payment, the use of nucleic acid detection methods for early screening and precise detection in the prevention and control of major diseases such as tuberculosis, cervical cancer, liver disease and other livelihood projects.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.